Evidence map›Paper›PMID 42662071›Full record

ArticleHealth science reports2026

Serosurvey of Toxoplasmosis Among Drug Users in Fars Province, Southern Iran: A Cross-Sectional Study.

Mohammad Reza Cheraghi, Mina Zarrabi, Sara Shahriarirad, Sahel Rohampour, Ghazal Shayan, Mostafa Omidian, Elham Rezaee, Jamal Sarvari, Abolfazl Gheshlaghi, Qasem Asgari and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Health science reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Mohammad Reza CheraghiStudent Research Committee Shiraz University of Medical Sciences Shiraz Iran.ORCID https://orcid.org/0009-0004-0620-1513
Mina ZarrabiStudent Research Committee Shiraz University of Medical Sciences Shiraz Iran.ORCID https://orcid.org/0009-0004-6836-2013
Sara ShahriariradStudent Research Committee Shiraz University of Medical Sciences Shiraz Iran.ORCID https://orcid.org/0009-0000-7772-1664
Sahel RohampourStudent Research Committee Shiraz University of Medical Sciences Shiraz Iran.
Ghazal ShayanStudent Research Committee Shiraz University of Medical Sciences Shiraz Iran.
Mostafa OmidianDepartment of Parasitology and Mycology, School of Medicine Shiraz University of Medical Sciences Shiraz Iran.ORCID https://orcid.org/0000-0001-5065-5249
Elham RezaeeStudent Research Committee Shiraz University of Medical Sciences Shiraz Iran.ORCID https://orcid.org/0000-0002-8240-8565
Jamal SarvariDepartment of Microbiology, School of Medicine Shiraz University of Medical Sciences Shiraz Iran.ORCID https://orcid.org/0000-0002-2259-0836
Abolfazl GheshlaghiDepartment of Microbiology, School of Medicine Shiraz University of Medical Sciences Shiraz Iran.
Qasem AsgariDepartment of Parasitology and Mycology, School of Medicine Shiraz University of Medical Sciences Shiraz Iran.ORCID https://orcid.org/0000-0002-7945-2370
Bahador SarkariDepartment of Parasitology and Mycology, School of Medicine Shiraz University of Medical Sciences Shiraz Iran.ORCID https://orcid.org/0000-0003-2045-9057

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Aims: Methods: Subjects of the study were 1400 drug users. Blood samples were collected from each individual from June 2023 to April 2024. Results: The majority (52.7%) of the participants were aged 40-60 years, with 83.4% living in urban areas. Males constituted 92.8% and females 7.2% of the subjects. Anti- Conclusion: Findings of the current study underscore the need for targeted public health interventions to address the risk of toxoplasmosis in this vulnerable population, particularly among those who use injection drugs. Further research is warranted to explore the underlying factors contributing to

Indexed as

Iranseroprevalencesubstance use disorderToxoplasma

Identifiers

PMID42662071
PMCPMC13519101

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.